Benign paroxysmal positional vertigo differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 270: | Line 270: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* History of migraine headaches | * History of [[migraine headaches]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* They may have white-matter hyperintensities (WMHs) on MRI | * They may have [[White matter|white-matter]] hyperintensities (WMHs) on [[MRI]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* ICHD-3 criteria | * ICHD-3 criteria | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* It may be associated with anxiety and depression | * It may be associated with [[anxiety]] and [[depression]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | ||
Line 285: | Line 285: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* They may experience loss of consciousness and motor/sensory problems | * They may experience [[loss of consciousness]] and motor/sensory problems | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* EEG | * [[EEG]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* They response well to anti-seizure drugs | * They response well to anti-seizure drugs | ||
Line 299: | Line 299: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Lhermitte's sign | * [[Lhermitte's sign]] | ||
* Spasticity | * [[Spasticity]] | ||
* Increased [[reflexes]] | * Increased [[reflexes]] | ||
* [[Internuclear ophthalmoplegia]] | * [[Internuclear ophthalmoplegia]] | ||
* Optic neuritis | * [[Optic neuritis]] | ||
* [[Gait disturbance]] | * [[Gait disturbance]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Brain atrophy and some [[contrast]] enhancing plaques on CT scan | * [[Cerebral atrophy|Brain atrophy]] and some [[contrast]] enhancing plaques on [[CT scan]] | ||
* Cerebral plaques disseminating in space and time on MRI | * Cerebral plaques disseminating in space and time on [[MRI scan|MRI]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History and physical examination]] | * [[History and Physical examination|History and physical examination]] | ||
Line 323: | Line 323: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Papilledema | * [[Papilledema]] | ||
* Focal neurological deficits | * [[Focal neurological deficits]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Cerebral spinal fluid ([[CSF]]) may show cancerous cells | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Cerebral spinal fluid ([[CSF]]) may show cancerous cells | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* On CT scan most of the brain tumors appears as a hypodense mass lesions | * On [[CT scan]] most of the [[brain tumors]] appears as a hypodense mass lesions | ||
* On MRI most of the brain tumors appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI. | * On [[MRI scan|MRI]] most of the [[brain tumors]] appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted [[MRI contrast agent|MRI]]. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Imaging | * [[Imaging]] | ||
* Biopsy | * [[Biopsy forceps|Biopsy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Patieny may experience [[headache]], [[seizures]], visual changes and changes in personality, mood and concentration | * Patieny may experience [[headache]], [[seizures]], [[Visual disturbance|visual changes]] and changes in [[personality]], [[mood]] and [[concentration]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage |
Revision as of 14:50, 11 April 2019
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating [Disease name] from other Diseases
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As [disease name] +in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||
---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||
Lab Findings | Imaging | ||||||||
Acute onset | Recurrency | Nystagmus | Hearing problems | ||||||
Peripheral | |||||||||
BPPV | + | + | +/− | − | − | − |
| ||
Vestibular neuritis | + | +/− | + /−
(unilateral) |
− |
|
− | − |
| |
HSV oticus | + | +/− | − | +/− |
|
+ VZV antibody titres |
|
||
Meniere disease | +/− | + | +/− | + (Progressive) | − |
|
|
||
Labyrinthine concussion | + | − | − | + | − |
|
| ||
Perilymphatic fistula | +/− | + | − | + | − |
|
| ||
Semicircular canal
dehiscence syndrome |
+/− | + | − | +
(air-bone gaps on audiometry) |
− |
|
| ||
Vestibular paroxysmia | + | + | +/−
(Induced by hyperventilation) |
− |
|
− |
|
|
|
Cogan syndrome | − | + | +/− | + | Increased ESR and cryoglobulins |
|
| ||
Vestibular schwannoma | − | + | +/− | + |
|
− |
| ||
Otitis media | + | − | − | +/− |
|
Increased acute phase reactants |
|
| |
Aminoglycoside toxicity | + | − | − | + | − | − |
| ||
Recurrent vestibulopathy | + | − | − | − | − | − | − |
| |
Central | |||||||||
Vestibular migrain | – | + | +/− | +/− |
|
− |
|
|
|
Epileptic vertigo | − | + | +/− | − |
|
− | − |
| |
Multiple sclerosis | − | + | +/− | − | Elevated concentration of CSF oligoclonal bands |
|
|||
Brain tumors | +/− | + | + | + | Cerebral spinal fluid (CSF) may show cancerous cells |
|
| ||
Crebellar infarction/hemorrhage | + | ||||||||
Brain stem ischemia | + | ||||||||
Chiari malformation | − | ||||||||
Parkinson | − |